Exercise News and Research

Latest Exercise News and Research

Increased BMI levels not attributed to sugar consumption: Study

A new independent study of scientific research has revealed that, contrary to the widely held hypothesis, dietary sugars are not the driving factor behind rising body mass index (BMI) levels in children in Great Britain.

27 May 2010

Health Canada approves Victoza for treatment of adults with type 2 diabetes

Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.

27 May 2010

Regular weightlifting exercise and milk consumption improve women's body composition, health: Study

Women who drink two large glasses of milk a day after their weight-lifting routine gained more muscle and lost more fat compared to women who drank sugar-based energy drinks, a McMaster study has found.

27 May 2010

Research shows reduced consumption of SSB lowers blood pressure

Drinking fewer sugar-sweetened beverages — a leading source of added sugar in the U.S. diet — may lower blood pressure, according to research published in Circulation: Journal of the American Heart Association.

26 May 2010

G7 aid delivers 'impressive results,' commitment falls short of 2005 pledge

According to an annual ONE report, which tracks progress on aid commitments made at the 2005 G8 summit in Gleneagles, Scotland, the G7 - Canada, France, Germany, Italy, Japan, the United Kingdom and the U.S. - is "on track to deliver 61 percent of their combined commitments to sub-Saharan Africa, or $13.7 billion of the $22.6 billion increase they promised," allAfrica.com reports.

26 May 2010

Visually-guided laser-balloon catheter stops abnormal electrical pulses in patients with irregular heartbeats

A new treatment known as a visually-guided laser-balloon catheter successfully interrupted abnormal electrical pulses in patients and pigs with intermittent, irregular heartbeats, in a study reported in Circulation: Arrhythmia and Electrophysiology, a journal of the American Heart Association.

26 May 2010

Philips Livable Cities Award for improving health and well-being of people living in cities

Royal Philips Electronics today announced the launch of the Philips Livable Cities Award, an initiative designed to generate practical, achievable ideas for improving the health and well-being of people living in cities. Individuals, community or non-governmental groups and businesses are eligible to participate in the Award program that comprises a total prize fund amounting to 125,000 Euros.

26 May 2010

New approach to prevention and management of Alzheimer's disease

With the aging of nearly 80 million baby boomers, Alzheimer's disease is an impending epidemic that requires a new approach to prevention as well as management of the disease, according to a UC Santa Barbara professor who has co-authored a new book on the topic.

26 May 2010

Applied Spine Technologies awarded U.S. patents for 'Dynamic Spine Stabilizer' and 'Spring Junction'

Applied Spine Technologies, Inc., a medical device company focused on motion preservation of the lumbar spine, was awarded two new patents by the U.S. Patent and Trademark Office on May 11, 2010.

25 May 2010

La Jolla Pharmaceutical announces $16.3 million private placement

La Jolla Pharmaceutical Company announced today that the Company has entered into definitive agreements with institutional investors and affiliates for a private placement of common stock, convertible preferred stock and warrants to purchase convertible preferred stock totaling up to $16.3 million in gross proceeds.

25 May 2010

MAQUET Cardiovascular commences enrollment in trial of FUSION and FUSION BIOLINE Vascular Grafts

MAQUET Cardiovascular LLC today announced enrollment of the first patient in FINEST (FUSION Vascular Graft, FUSION Vascular Graft with BIOLINE and EXXCEL SOFT ePTFE). This prospective, randomized, single-blind, three-arm, parallel group, multi-center study is evaluating the safety and efficacy of MAQUET's investigational FUSION Vascular Graft and FUSION BIOLINE Vascular Graft, compared with its commercially available EXXCEL Soft ePTFE Vascular Graft in peripheral artery bypass surgery.

25 May 2010

First Edition: May 25, 2010

Today's headlines reflect health policy action at the federal level as the Obama administration issues a warning to the insurance industry about mergers and urges the courts to dismiss Virginia's lawsuit against the health reform law.

25 May 2010

Excessive amounts of HSP10 inside mitochondria can halt body's ageing process: Researchers

HSP10 (Heat Shock Protein), helps monitor and organise protein interactions in the body, and responds to environmental stresses, such as exercise and infection, by increasing its production inside cells. Researchers at Liverpool, in collaboration with colleagues at the University of California, found that excessive amounts of HSP10 inside mitochondria - 'organs' that act as energy generators in cells - can halt the body's ageing process by preserving muscle strength.

25 May 2010

Researchers examine relationship between visiting primary care physician and effect blood pressure

Frequent doctor visits helped diabetes patients lower their high blood pressure to normal quicker, according to a large study reported in Hypertension: Journal of the American Heart Association.

25 May 2010

Researchers explore impact of asymptomatic LV dysfunction in vascular surgery patients

Symptomatic heart failure prior to surgery is routinely acknowledged as a risk factor for adverse outcomes for both cardiac and non-cardiac surgeries. In a new study published in the June Anesthesiology, researchers delve further into the implications of cardiac problems on postoperative outcomes, exploring preoperative diagnosis and impact of asymptomatic left ventricular dysfunction in vascular surgery patients.

25 May 2010

One-third of Minnesotans understate their weight problems

When it comes to self-perceptions about their own healthy weight, many Minnesotans appear to be adapting Garrison Keillor's famous quip: "I believe in looking reality straight in the eye and denying it."

25 May 2010

Phase 1 clinical trial of OXY111A initiated

NormOxys Inc., a biotechnology company developing a novel class of small molecule drugs which enhance the body's ability to deliver oxygen to diseased tissues, today announced that it has initiated a Phase 1 clinical trial of OXY111A, a novel allosteric modulator of affinity of oxygen to hemoglobin. NormOxys plans to initially develop this compound as a treatment for chronic heart failure and cancer indications.

24 May 2010

South Dakota State University mathematicians design mathematical models to treat cancer

South Dakota State University mathematicians are helping doctors of the Mayo Clinic build mathematical models to fine-tune an innovative strategy to treat cancer.

24 May 2010

Cell Therapeutics signs agreement to sell $21.0M of shares of Series 5 Preferred Stock

Cell Therapeutics, Inc. today announced that it has entered into an agreement to sell $21.0 million of shares of its Series 5 Preferred Stock in a registered offering to three institutional investors (collectively, the "Initial Purchasers"). Each share of Series 5 Preferred Stock is convertible at the option of the holder, at any time during its existence, into 2,500 shares of common stock at a conversion price of $0.40 per share of common stock, for a total of 52,500,000 shares of common stock.

24 May 2010

Researchers analyze impact of health promotion program on cardiovascular disease-related medical, hospital costs

A comprehensive health promotion program reduced cardiovascular disease-related medical and hospital costs, according to a new study. CSX Transportation, a national company with 30,000 employees, developed the program in 2004 to address employees' high rates of cardiovascular disease when compared to national benchmarks and the associated higher healthcare costs.

21 May 2010

Exercise News and Research

Latest Exercise News and Research

Increased BMI levels not attributed to sugar consumption: Study

Health Canada approves Victoza for treatment of adults with type 2 diabetes

Regular weightlifting exercise and milk consumption improve women's body composition, health: Study

Research shows reduced consumption of SSB lowers blood pressure

G7 aid delivers 'impressive results,' commitment falls short of 2005 pledge

Visually-guided laser-balloon catheter stops abnormal electrical pulses in patients with irregular heartbeats

Philips Livable Cities Award for improving health and well-being of people living in cities

New approach to prevention and management of Alzheimer's disease

Applied Spine Technologies awarded U.S. patents for 'Dynamic Spine Stabilizer' and 'Spring Junction'

La Jolla Pharmaceutical announces $16.3 million private placement

MAQUET Cardiovascular commences enrollment in trial of FUSION and FUSION BIOLINE Vascular Grafts

First Edition: May 25, 2010

Excessive amounts of HSP10 inside mitochondria can halt body's ageing process: Researchers

Researchers examine relationship between visiting primary care physician and effect blood pressure

Researchers explore impact of asymptomatic LV dysfunction in vascular surgery patients

One-third of Minnesotans understate their weight problems

Phase 1 clinical trial of OXY111A initiated

South Dakota State University mathematicians design mathematical models to treat cancer

Cell Therapeutics signs agreement to sell $21.0M of shares of Series 5 Preferred Stock

Researchers analyze impact of health promotion program on cardiovascular disease-related medical, hospital costs

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exercise News and Research

Latest Exercise News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in